Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Determination of drug-metabolizing enzyme activity in vivo: pharmacokinetic and statistical issues.

Literature DB >> 9890160

Determination of drug-metabolizing enzyme activity in vivo: pharmacokinetic and statistical issues.

G T Tucker¹, A Rostami-Hodjegan, P R Jackson.

Abstract

Mesh：

Substances：

Year: 1998 PMID： 9890160 DOI： 10.1080/004982598238895

Source DB: PubMed Journal: Xenobiotica ISSN： 0049-8254 Impact factor: 1.908

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. CYP1A2, GSTM1, and GSTT1 polymorphisms and diet effects on CYP1A2 activity in a crossover feeding trial.

Authors: Sabrina Peterson; Yvonne Schwarz; Shuying S Li; Lin Li; Irena B King; Chu Chen; David L Eaton; John D Potter; Johanna W Lampe
Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-10-20 Impact factor: 4.254

2. Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?

Authors: Sibylle Neuhoff; Geoffrey T Tucker
Journal: Br J Clin Pharmacol Date: 2018-02-21 Impact factor: 4.335

3. The influence of sex, ethnicity, and CYP2B6 genotype on bupropion metabolism as an index of hepatic CYP2B6 activity in humans.

Authors: Katarina Ilic; Roy L Hawke; Ranjit K Thirumaran; Erin G Schuetz; J Heyward Hull; Angela D M Kashuba; Paul W Stewart; Celeste M Lindley; Mei-Ling Chen
Journal: Drug Metab Dispos Date: 2012-12-13 Impact factor: 3.922

4. The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans.

Authors: Joseph Bloom; Anthony L Hinrichs; Jen C Wang; Linda B von Weymarn; Evan D Kharasch; Laura J Bierut; Alison Goate; Sharon E Murphy
Journal: Pharmacogenet Genomics Date: 2011-07 Impact factor: 2.089

5. Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects.

Authors: Eloise A Gelston; Janet K Coller; Olga V Lopatko; Heather M James; Helmut Schmidt; Jason M White; Andrew A Somogyi
Journal: Br J Clin Pharmacol Date: 2012-05 Impact factor: 4.335

Determination of drug-metabolizing enzyme activity in vivo: pharmacokinetic and statistical issues.

1. CYP1A2, GSTM1, and GSTT1 polymorphisms and diet effects on CYP1A2 activity in a crossover feeding trial.

2. Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?

3. The influence of sex, ethnicity, and CYP2B6 genotype on bupropion metabolism as an index of hepatic CYP2B6 activity in humans.

4. The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans.

5. Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects.

6. NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios.

7. Effect of dehusked Garcinia kola seeds on the overall pharmacokinetics of quinine in healthy Nigerian volunteers.

8. Ontogeny of midazolam glucuronidation in preterm infants.